signatures mutation selection cancer genome 
cancer genome moulded dual processes somatic mutation selection homozygous deletions cancer genomes occur recessive cancer genes can confer selective growth advantage fragile sites thought reflect increased local rate dna breakage however homozygous deletions cancer genomes unexplained identified somatic homozygous deletions cancer cell lines overlie % protein-coding genes therefore mandatory survival human cells derived structural signatures distinguish homozygous deletions recessive cancer genes fragile sites application clusters unexplained homozygous deletions suggests many regions inherent fragility whereas small subset overlies recessive cancer genes results illustrate structural signatures can used distinguish influences mutation selection cancer genomes extensive copy number genotyping sequence expression data available large series publicly available cancer cell lines renders informative reagents future studies cancer biology drug discovery 
